Lanean...

Nonmyeloablative Unrelated Donor Hematopoietic Cell Transplantation for the Treatment of Patients with Poor-Risk, Relapsed or Refractory Multiple Myeloma

The purpose of this study was to determine long-term outcome of unrelated donor nonmyeloablative hematopoietic cell transplantation in patients with poor-risk multiple myeloma. Twenty-four patients were enrolled. Seventeen patients (71%) had chemotherapy-refractory disease and 14 patients (58%) had...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Georges, George E., Maris, Michael B., Maloney, David G., Sandmaier, Brenda M., Sorror, Mohamed L., Shizuru, Judith A., Niederwieser, Dietger W., Agura, Edward D., Bruno, Benedetto, McSweeney, Peter A., Pulsipher, Michael A., Chauncey, Thomas R., Mielcarek, Marco, Storer, Barry E., Storb, Rainer
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2007
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1950939/
https://ncbi.nlm.nih.gov/pubmed/17287157
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2006.11.011
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!